Optimising medicines use in older adults with intellectual disability who have epilepsy: challenges and perspectives
Ther Adv Drug Saf
.
2021 Aug 4:12:20420986211025157.
doi: 10.1177/20420986211025157.
eCollection 2021.
Authors
Maire O'Dwyer
1
,
Lance Watkins
2
,
Philip McCallion
3
,
Mary McCarron
4
,
Martin Henman
5
,
Rohit Shankar
6
Affiliations
1
School of Pharmacy and Pharmaceutical Sciences, University of Dublin Trinity College, Dublin, 2, Ireland.
2
Swansea Bay University Health Board Ringgold Standard Institution, Neath Port Talbot, UK.
3
School of Social Work, College of Public Health, Temple University, Philadelphia, PA, USA.
4
Trinity Centre for Ageing and Intellectual Disability, School of Nursing and Midwifery, University of Dublin, Trinity College Dublin, Ireland.
5
School of Pharmacy and Pharmaceutical Sciences, University of Dublin Trinity College, Dublin, Ireland.
6
Cornwall Partnership NHS Foundation Trust, Threemilestone Industrial Estate, Truro, UK, and Exeter Medical School, Knowledge Spa, Royal Cornwall Hospital, Truro, UK.
PMID:
34394909
PMCID:
PMC8361510
DOI:
10.1177/20420986211025157
No abstract available
Keywords:
anti-seizure drugs; epilepsy; intellectual disability; polypharmacy; seizures.
Publication types
Editorial